Medicine Description montulair 4mg
Montulair 4 mg 20 tablets is a medication that contains montelukast, which functions as a selective leukotriene receptor antagonist. By binding to cysteinyl leukotriene receptors in the airway, it inhibits the action of leukotrienes, which are inflammatory mediators that contribute to bronchoconstriction, mucus secretion, and airway edema. This blockade results in relaxation of the bronchial muscles, reduction in mucus production, and overall improvement in airway patency. Consequently, patients experience enhanced airflow and diminished respiratory symptoms such as wheezing, coughing, and chest tightness. Montelukast also plays a role in managing allergic rhinitis symptoms by mitigating the inflammatory response associated with allergens.
Indications and Uses of Montulair 4 mg 20 tablets
- Management of asthma in adults and children 2 years of age and older.
- Prevention of exercise-induced bronchoconstriction.
- Treatment of seasonal allergic rhinitis in patients aged 2 years and older.
- Management of perennial allergic rhinitis in individuals aged 6 months and older.
Side Effects of Montulair 4 mg 20 tablets
- Headache
- Gastrointestinal disturbances (e.g., abdominal pain, nausea)
- Fatigue
- Somnolence
- Behavioral changes (e.g., mood swings, anxiety)
- Skin rashes
Storage and Handling
Store Montulair 4 mg 20 tablets at room temperature, away from moisture and heat. Keep out of reach of children and do not use past the expiration date printed on the packaging.
Patient Advice and Precautions
Patients should use Montulair regularly as prescribed, without substituting it for immediate relief medications during an asthma attack. It is essential to inform healthcare providers about any pre-existing conditions or other medications being taken. Regular follow-up appointments are important to monitor asthma control and adjust treatment as necessary. Be aware of potential behavioral changes and report any unusual symptoms to a healthcare professional promptly.